Drugs / AL-38583
last change Apr 2010 re-read 3 minutes ago

AL-38583

Developed for
conjunctivitis · dry eye syndrome
Investigated by
Alcon Research · Ophthalmic Research Associates, Inc.

Trials 3

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01001091 Dec 2009 → Apr 2010 conjunctivitis Alcon Research Completed No outcome recorded
Phase 2 NCT00893139 Jun 2009 → Jan 2010 dry eye syndrome Alcon Research Completed No outcome recorded
Phase 2 NCT00881673 May 2009 conjunctivitis Alcon Research Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as AL-38583 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01001091 ↗
2

NCT00881673 ↗

NCT00893139 ↗

Route Topical “Topical ophthalmic” NCT00881673 ↗